MedPath

Tranexamic Acid in Sleeve Gastrectomy

Not Applicable
Completed
Conditions
Tranexamic Acid Adverse Reaction
Registration Number
NCT05696951
Lead Sponsor
Goztepe Prof Dr Suleyman Yalcın City Hospital
Brief Summary

The effectiveness of Tranexamic acid use will be measured in cases of sleeve gastrectomy in bariatric surgery and in early postoperative bleeding.

Detailed Description

Prospective, comparative and double-blind study with patients aged 18-65 years admitted to bariatric surgery. Selected patients were given or not given venous tranexamic acid (TXA) during anesthesia induction (CG). Anesthesia and thromboprophylaxis protocols were similar between groups. For statistical analysis, χ2 and analysis of variance tests were performed using the SPSS 21.0 ® statistical program at a significance level of p \< 0.05.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients aged 18 to 65 years with an American Association of Anesthesiologists (ASA) physical condition score II or III
  • undergoing bariatric surgery and LSG
Exclusion Criteria
  • history of thromboembolic disease or severe comorbidity (ASA IV or more)
  • platelet antiaggregants or anticoagulants
  • active intravascular coagulation carriers
  • acute occlusive vasculopathy
  • hypersensitivity to the components of the TXA formula.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
effect on bleeding in the first one hours postoperativelypostoperative 1st hours

postoperative bleeding

Secondary Outcome Measures
NameTimeMethod
effect on bleeding in the first 24 hours postoperativelypostoperative 24st hours

The effect of tranexamic acid on early postoperative bleeding

Trial Locations

Locations (1)

Göztepe Prof. Dr. Suleyman Yalcin City Hospital

🇹🇷

Kadıköy, İstanbul, Turkey

Göztepe Prof. Dr. Suleyman Yalcin City Hospital
🇹🇷Kadıköy, İstanbul, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.